Valuation: China Isotope & Radiation Corporation

Market Cap 4.91B 5.67B 723M 635M 585M 547M 1.03B 68.21B 1.04B 7.02B 2.72B 33.63B 2.71B 2.66B 117B P/E 2024
8.03x
P/E 2025 17.7x
Enterprise Value 5.03B 5.81B 740M 650M 599M 560M 1.05B 69.86B 1.07B 7.19B 2.78B 34.44B 2.78B 2.72B 120B EV / Sales 2024
0.42x
EV / Sales 2025 0.82x
Free-Float
91.21%
Yield 2024
3.74%
Yield 2025 1.69%
Jun. 18 China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026 CI
Jun. 18 China Isotope & Radiation Corporation Appoints Zhang Guoliang as A Member of Legal Affairs Committee of the Board and A Member of Science and Technology Innovation Committee of the Board CI
May. 26 China Isotope Proposes Auditor Change MT
May. 26 China Isotope & Radiation Corporation Announces Ma Xiaoyu Resignation of Ma Xiaoyu as an Executive Director Member of the Legal Affairs Committee Science and Technology Innovation Committee, Effective May 26, 2026 CI
Mar. 27 China Isotope & Radiation final cash dividend of RMB0.2264 per share RE
Mar. 27 China Isotope & Radiation Corporation Proposes Final Dividend for the Year Ended December 31, 2025, Payable Before 17 August 2026 CI
Mar. 27 China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 CI
Mar. 19 China Isotope & Radiation to buy 51% stake in Hunan Huifeng Engineering Detection RE
Mar. 13 China Isotope & Radiation Corporation, Zhonghe Headway and the People?s Government of Maoming Municipality Enter Strategic Cooperation Agreement CI
Mar. 13 China Isotope & Radiation says co and Zhonghe Headway enter strategic cooperation agreement with Maoming municipality RE
Mar. 02 China Isotope & Radiation's Unit Gets China Nod for Market Launch of Breath Analyzer MT
Feb. 12 China Isotope & Radiation Warns of Up to 25% Lower 2025 Profit MT
Feb. 12 China Isotope & Radiation Corporation Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025 CI
1 day-2.37%
1 week-7.98%
Current month-3.73%
1 month-1.03%
3 months-15.94%
6 months-14.78%
Current year-14.36%
1 week 17.02
Extreme 17.02
19.99
1 month 17.02
Extreme 17.02
20.22
Current year 17.02
Extreme 17.02
24.28
1 year 14.28
Extreme 14.28
25
3 years 9.03
Extreme 9.03
25
5 years 9.03
Extreme 9.03
32.1
10 years 9.03
Extreme 9.03
35.4
Manager TitleAgeSince
Chief Executive Officer 55 2024-08-01
Corporate Secretary - 2024-08-29
Corporate Secretary - 2024-08-29
Director TitleAgeSince
Director/Board Member 57 2017-02-21
Director/Board Member 54 2019-06-27
Director/Board Member 54 2019-12-29
Change 5-day change 1-year change 3-year change Capi.($)
-2.37%-7.98%+15.64%+10.33% 723M
+4.37%+8.47%+186.45%+302.31% 18.95B
+0.50%+2.10%-41.14%-21.98% 9.41B
+3.97%+4.96%+35.33%+17.82% 7.1B
+3.03%+1.25%-29.25% - 5.29B
+2.11%+1.38%-25.78%-31.24% 4.92B
+3.27%+2.81%+206.43%-34.58% 4.54B
+5.55%-2.29%+97.99%+101.60% 4.42B
+1.33%+3.38%-28.45%-29.39% 4.01B
-0.87%-2.92%-21.23%-44.47% 2.49B
Average +2.09%+1.28%+39.60%+30.04% 6.19B
Weighted average by Cap. +2.96%+4.05%+70.01%+98.42%

Financials

2024 2025
Net sales 7.57B 8.74B 1.11B 979M 902M 843M 1.58B 105B 1.61B 10.82B 4.19B 51.84B 4.19B 4.09B 180B 7.19B 8.29B 1.06B 929M 856M 800M 1.5B 99.8B 1.53B 10.27B 3.98B 49.2B 3.97B 3.88B 171B
Net income 407M 469M 59.84M 52.56M 48.43M 45.28M 84.92M 5.65B 86.48M 581M 225M 2.78B 225M 220M 9.67B 327M 378M 48.18M 42.32M 38.99M 36.46M 68.38M 4.55B 69.63M 468M 181M 2.24B 181M 177M 7.79B
Net Debt -109M -126M -16.03M -14.08M -12.97M -12.13M -22.75M -1.51B -23.17M -156M -60.29M -746M -60.19M -58.87M -2.59B 119M 137M 17.49M 15.36M 14.15M 13.23M 24.82M 1.65B 25.27M 170M 65.77M 813M 65.67M 64.23M 2.83B
Logo China Isotope & Radiation Corporation
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Employees
3,578
Date Price Change Volume
26-06-26 HK$17.30 -2.37% 66,600
26-06-25 HK$17.72 +0.28% 190,800
26-06-24 HK$17.67 -1.78% 109,600
26-06-23 HK$17.99 -4.31% 111,400
26-06-22 HK$18.80 -3.29% 137,400

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1763 Stock